Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P01189 (
beta-endorphin
)
21,003
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Hyperpigmentation believed to be due to melanin, is a feature of chronic liver disease, especially
primary biliary cirrhosis
and hemochromatosis. Normal plasma concentrations of immunoreactive
beta-melanocyte-stimulating hormone
(
beta-MSH
) have been found in both these conditions; thus elevation of plasma
beta-MSH
plays no role in the pathogenesis of hepatic pigmentation. Normal levels are also found in hepatocellular failure, which supports the hypothesis that the kidney and not the liver is the site of metabolism of this hormone.
...
PMID:Plasma immunoreactive beta-melanocyte-stimulating hormone in chronic liver disease and fulminant hepatic failure. 64 79
Regenerated adrenocortical nodules were obtained by implanting in the musculus gracilis of rats fragments of the capsular tissue of their excised adrenal glands. Five months after operation, transplanted rats showed a slightly elevated blood concentration of
adrenocorticotropin
(ACTH), a moderately reduced plasma level of corticosterone (
PBC
) and a very low concentration of circulating aldosterone (PAC). Regenerated nodules were well encapsulated, and from the connective capsule some septa dipped into the parenchyma. Subcapsular-outer (OZ) and inner (IZ) cells were similar to those of the zona fasciculata/zona reticularis (ZF/ZR) of the normal gland; juxta-septal (JZ) cells resembled those of the zona glomerulosa (ZG). Prolonged (14 days) ACTH infusion normalized
PBC
and caused a conspicuous hypertrophy of transplanted tissue, which was coupled with a marked hypertrophy of ZF/ZR-like OZ and IZ cells and a notable rise in the basal in vitro production of corticosterone. Conversely, ACTH infusion strikingly lowered PAC, reduced the number of ZG-like JZ cells, and decreased both basal and stimulated secretion of 18-hydroxylated steroids by transplants in vitro.
...
PMID:Effects of prolonged treatment with adrenocorticotropin on the morphology and function of rat adrenocortical autotransplants. 185 75
A histological and ultrastructural study has demonstrated that cutaneous pigmentation in
primary biliary cirrhosis
(
PBC
) is due to the presence of increased amounts of melanin, widely dispersed throughout both epidermis and dermis. No deposits of stainable iron were observed. Compared with skin from matched sites from control patients with alcoholic cirrhosis and no pigmentation, the melanocyte: keratinocyte ratio was not significantly higher in
PBC
. However, in
PBC
, melanosomes persisted to unusually high levels in the epidermis and were packaged in larger membrane-bound clusters than was the case in the controls. Whether excess melanin results from increased melanogenesis or defective melanin degradation remains unclear, although there is some evidence favouring the latter mechanism. No hormonal (
beta-MSH
and ACTH) or chemical (bile salt irritation) stimuli to increase melanogenesis were demonstrated.
...
PMID:Melanin pigmentation of the skin in primary biliary cirrhosis. 627 1
Seventy-two long-surviving liver transplant recipients were evaluated prospectively, including a baseline allograft biopsy for weaning off of immunosuppression. Thirteen were removed from candidacy because of chronic rejection (n = 4), hepatitis (n = 2), patient anxiety (n = 5), or lack of cooperation by the local physician (n = 2). The other 59, aged 12-68 years, had stepwise drug weaning with weekly or biweekly monitoring of liver function tests. Their original diagnoses were
PBC
(n = 9), HCC (n = 1), Wilson's disease (n = 4), hepatitides (n = 15), Laennec's cirrhosis (n = 1), biliary atresia (n = 16), cystic fibrosis (n = 1), hemochromatosis (n = 1), hepatic trauma (n = 1), alpha-1-antitrypsin deficiency (n = 9), and secondary biliary cirrhosis (n = 1). Most of the patients had complications of long-term immunosuppression, of which the most significant were renal dysfunction (n = 8), squamous cell carcinoma (n = 2) or verruca vulgaris of skin (n = 9), osteoporosis and/or arthritis (n = 12), obesity (n = 3), hypertension (n = 11), and opportunistic infections (n = 2). When azathioprine was a third drug, it was stopped first. Otherwise, weaning began with prednisone, using the results of
corticotropin
stimulation testing as a guide. If adrenal insufficiency was diagnosed, patients reduced to < 5 mg/day prednisone were considered off of steroids. The baseline agents (azathioprine, cyclosporine, or FK506) were then gradually reduced in monthly decrements. Complete weaning was accomplished in 16 patients (27.1%) with 3-19 months drug-free follow-up, is progressing in 28 (47.4%), and failed in 15 (25.4%) without graft losses or demonstrable loss of graft function from the rejections. This and our previous experience with self-weaned and other patients off of immunosuppression indicate that a significant percentage of appropriately selected long-surviving liver recipients can unknowingly achieve drug-free graft acceptance. Such attempts should not be contemplated until 5-10 years posttransplantation and then only with careful case selection, close monitoring, and prompt reinstitution of immunosuppression when necessary.
...
PMID:Weaning of immunosuppression in long-term liver transplant recipients. 783 42
Increased activation of lymphocytes in inflammatory bowel disease is reflected by alterations of various immunological functions including enhanced spontaneous secretion of rheumatoid factor by mononuclear cells. since in rheumatic diseases increased secretion of rheumatoid factor is associated with decreased levels of
beta-endorphin
in circulating blood mononuclear leukocytes, we investigated levels of leukocyte
beta-endorphin
in inflammatory bowel disease and compared them with those in hepatobiliary disorders and in healthy subjects. Levels of
beta-endorphin
were measured in extracts from peripheral blood mononuclear leukocytes by radioimmunoassay. beta-Endorphin levels ranged from 0 to 67 pg/10(6) cells. Mononuclear leukocytes from ulcerative colitis patients contained as much
beta-endorphin
as those from healthy control subjects. In patients with Crohn's disease, levels of
beta-endorphin
were reduced by as much as roughly 50%. An inverse relationship was found between leukocyte
beta-endorphin
on the one hand and erythrocyte sedimentation rate, blood granulocyte or thrombocyte counts, and C-reactive protein levels in plasma on the other. In patients with various hepatobiliary disorders including fatty liver disease, viral hepatitis,
primary biliary cirrhosis
, and cryptogenic or alcoholic cirrhosis,
beta-endorphin
levels were not significantly different from the normal range values. Data indicate that leukocyte
beta-endorphin
may be involved in regulation of the systemic inflammatory activity of Crohn's disease.
...
PMID:Decreased beta-endorphin content in peripheral blood mononuclear leukocytes from patients with Crohn's disease. 786 97